BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24277483)

  • 1. Disorders of hemostasis in overt and subclinical hypercortisolism.
    Świątkowska-Stodulska R; Sworczak K
    Exp Clin Endocrinol Diabetes; 2013 Nov; 121(10):588-94. PubMed ID: 24277483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypercortisolism and hemostasis].
    Swiatkowska-Stodulska R; Babińska A; Sworczak K
    Pol Merkur Lekarski; 2009 Feb; 26(152):142-4. PubMed ID: 19388521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic Disorders in Hormonally Active Pituitary Tumors.
    Świątkowska-Stodulska R; Babińska A; Mital A; Stodulski D; Sworczak K
    Exp Clin Endocrinol Diabetes; 2015 Oct; 123(9):548-52. PubMed ID: 26285071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid disorders and hypercoagulability.
    Erem C
    Semin Thromb Hemost; 2011 Feb; 37(1):17-26. PubMed ID: 21249601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subclinical hypercortisolism in incidentally detected adrenal adenoma].
    Seppel T; Schlaghecke R
    Dtsch Med Wochenschr; 1996 Apr; 121(16):503-7; discussion 508. PubMed ID: 8612460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The disturbance of hemostasis induced by hyperhomocysteinemia; the role of antioxidants.
    Malinowska J; Kolodziejczyk J; Olas B
    Acta Biochim Pol; 2012; 59(2):185-94. PubMed ID: 22577622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation and fibrinolysis in thyroid dysfunction.
    Erem C
    Endocrine; 2009 Aug; 36(1):110-8. PubMed ID: 19367377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemostatic disturbances in obesity].
    Swiatkowska-Stodulska R; Kazimierska E; Sworczak K; Czestochowska E
    Wiad Lek; 2007; 60(3-4):185-8. PubMed ID: 17726874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid dysfunction and hemostasis: an issue still unresolved.
    Franchini M; Montagnana M; Manzato F; Vescovi PP
    Semin Thromb Hemost; 2009 Apr; 35(3):288-94. PubMed ID: 19452404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemostatic disorders in liver disease].
    Mitrică D; Drug VL; Prelipcean CC; Stan M
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):313-20. PubMed ID: 19294997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
    Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemostasis disorders in severe infections: state of the art].
    Fourrier F
    Med Mal Infect; 2006 Jun; 36(6):304-13. PubMed ID: 16713162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological mechanisms of thromboembolism.
    Risberg B
    Acta Chir Scand Suppl; 1989; 550():104-14. PubMed ID: 2652960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: coagulation disorders in chronic liver disease.
    Peck-Radosavljevic M
    Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():21-8. PubMed ID: 17958516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of pituitary, adrenal, and parathyroid hormones on hemostasis and thrombosis.
    Squizzato A; Van Zaane B; Gerdes VE; Büller HR
    Semin Thromb Hemost; 2011 Feb; 37(1):41-8. PubMed ID: 21249603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic disorders in type 1 diabetes mellitus.
    Targher G; Chonchol M; Zoppini G; Franchini M
    Semin Thromb Hemost; 2011 Feb; 37(1):58-65. PubMed ID: 21249604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement].
    Sokołowska B; Piecuch W; Walter-Croneck A; Dmoszyńska A; Furmanik F
    Przegl Lek; 2002; 59(7):502-8. PubMed ID: 12516238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.